Express Pharma
Home  »  Latest Updates  »  Hester Biosciences gets listed on NSE

Hester Biosciences gets listed on NSE

3

The shares were listed at Rs 523.95 per share

Shares of Ahmedabad-based Hester Biosciences recently got listed on the National Stock Exchange (NSE). The shares were listed at Rs 523.95 per share. The company’s shares are listed on the Bombay Stock Exchange (BSE) since 1994.

“We are happy that our company’s shares are listed on both the premier stock exchanges. Listing on NSE will further increase liquidity of the company’s shares,” said Rajiv Gandhi, Chief Executive and Officer and Managing Director, Hester Biosciences.

Hester Biosciences’ product portfolio comprises of over 45 vaccines and over 35 health products. Hester has a state-of-the-art manufacturing facility, having WHO-GMP, ISO 9001, ISO 14001, OHSAS 18001 & GLP certifications. As on December 31, 2014, the promoter group held 53.84 per cent in the company while individual retail shareholders holds around 31.61 per cent. Ladderup Finance and Oaklane Capital Management hold one per cent and 1.32 per cent respectively in the company.

For the FY 2013-14, the company reported net profit of Rs 10.09 crore on revenue of Rs 69.05 crore. “Going forward we expect to cross Rs 200-crore turnover by FY 16-17,” said Gandhi.

EP News BureauMumbai

Comments are closed.